Evidence map›Paper›PMID 30983870›Full record

ArticleTurkish journal of biology = Turk biyoloji dergisi2018

Effectiveness of bitter melon extract in the treatment of ischemic wounds in rats.

Öznur Gürlek Kisacik, Ülkü Güneş, Mustafa Volkan Yaprakçi, Korhan Altunbaş

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of biology = Turk biyoloji dergisi, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Suppression of Inflammatory Cytokines Expression with Bitter Melon (Journal of translational internal medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Öznur Gürlek KisacikDepartment of Basic Nursing, Faculty of Health Science, Afyonkarahisar Health Science University , Afyonkarahisar , Turkey.ORCID 0000-0002-1317-3141
Ülkü GüneşDepartment of Basic Nursing, Faculty of Nursing, Ege University , Bornova, İzmir , Turkey.ORCID 0000-0001-8104-5603
Mustafa Volkan YaprakçiDepartment of Surgery, Faculty of Veterinary Medicine, Afyon Kocatepe University , Afyonkarahisar , Turkey.ORCID 0000-0003-2793-4295
Korhan AltunbaşDepartment of Histology and Embryology, Faculty of Veterinary Medicine, Afyon Kocatepe University , Afyonkarahisar , Turkey.ORCID 0000-0001-7580-3412
Afyon Kocatepe University · TREge University · TRSağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is no consensus on the properties of an ideal dressing for treating wounds. The aim of this study was to investigate the efficacy of dressings using topically administered bitter melon extract with olive oil, pure olive oil, nitrofurazone, and saline in the healing of ischemic wounds. A sample group of 48 rats was used in the trial. Their wounds were treated with bitter melon extract, pure olive oil, nitrofurazone, and saline. Data were collected between October 2014 and April 2015. The highest percentage (94.7%) of wound healing was observed in the bitter melon extract group and the lowest percentage (86.3%) in the nitrofurazone group. At the end of the 21st day, macroscopic reepithelialization was observed in 9 wounds in the bitter melon extract group (75%), in 6 wounds in the pure olive oil group (50%), and in only 3 wounds in the nitrofurazone and saline groups (25%). It can be concluded that dressing with a bitter melon extract is more efficient in the treatment of wounds than using nitrofurazone or saline, and that dressing with olive oil accelerates wound healing, although not as much as dressing with bitter melon extract.

Indexed as

bitter melonIschemic woundMomordicawound dressing

Identifiers

PMID30983870
PMCPMC6451845
OpenAlexW2905120787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.